Sonoma Pharmaceuticals Inc.
01/02/2026 | Press release | Distributed by Public on 01/02/2026 16:19
Management Change/Compensation (Form 8-K)
| Item 5.02. | Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January 2, 2026, we completed our annual equity grant to employees, including executive officers, of the Company. The annual grant is intended to recognize employees who meet certain employment criteria and to retain key employees. The Company's non-employee directors each received 10,000 options. The exercise price of the options is based on the closing price of our common stock of $3.68 per share on January 2, 2026, and the options vest in three equal tranches on the first, second and third anniversary of the grant date. Each executive officer received Restricted Stock Units (RSUs) as follows:
| · | Amy Trombly, Chief Executive Officer: 10,000 RSUs; and | |
| · | Jerry Dvonch, Chief Financial Officer: 5,000 RSUs. |
The RSUs vest on the third anniversary of the grant date or upon change of control or as otherwise provided in an executive officer's employment agreement.
Sonoma Pharmaceuticals Inc. published this content on January 02, 2026, and is solely responsible for the information contained herein. Distributed via Edgar on January 02, 2026 at 22:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]